Sarepta Therapeutics' Elevidys for DMD shows revenue potential, with market cap justified at $11.4bn and potential for >50% ...

Moderna is down 80% from its 52-week high as revenues continue to fall and the new RSV vaccine has performed poorly. Read my ...

Glaukos GKOS recently announced positive data from a new 36-month follow-up analysis of its two Phase 3 pivotal clinical ...

Iron Road Ltd ( ($AU:IRD) ) has issued an announcement. Iron Road Ltd has announced significant progress in a Scoping Study conducted by WSP, ...

Electric vehicle (EV) stocks like Amara Raja, Bharat Electronics (BEL), Bharat Forge and Minda Corporation among others gained up to 6% in trade on Tuesday, January 14, following a study released ...

As the New Year ushers in the so-called Dry January movement, a recent study shows that no- and low-alcohol beverages are becoming increasingly popular, particularly among millennials.

The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study in patients with high-risk non-muscle invasive bladder cancer (NMIBC ...

The study, conducted across 15 top-rated tertiary care hospitals in India, focused on patients with severe infections, ...

The U.S. Securities and Exchange Commission (SEC) was extremely busy in 2024, finalizing a multitude of new rules. A few targeted exchanges and their fee structures, including reducing access fees and ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Some of the world’s biggest polluters are reaping billions of dollars through a lax form of green finance, a new ...

One such model is my "Bottom-spotting model," which has shown a history of spotting tactical trading bottoms in the last five years. In the past, this model has triggered buy signals whenever two or ...